No abstract available
MeSH terms
-
Atherosclerosis / diagnostic imaging
-
Atherosclerosis / drug therapy
-
Atherosclerosis / etiology
-
Atherosclerosis / prevention & control*
-
Cardiovascular Agents / therapeutic use
-
Cholesterol, LDL / blood
-
Consensus Development Conferences as Topic
-
Europe
-
Humans
-
Hypolipidemic Agents / therapeutic use
-
Life Style
-
Lipoprotein(a) / antagonists & inhibitors
-
Molecular Targeted Therapy
-
Oligonucleotides, Antisense / therapeutic use
-
Practice Guidelines as Topic
-
Precision Medicine / methods
-
Precision Medicine / trends
-
Proprotein Convertase 9
-
Proprotein Convertases / antagonists & inhibitors
-
Radionuclide Imaging
-
Risk Factors
-
Scotland
-
Sedentary Behavior
-
Serine Endopeptidases
-
Smoking / adverse effects
-
Societies, Medical
Substances
-
Cardiovascular Agents
-
Cholesterol, LDL
-
Hypolipidemic Agents
-
Lipoprotein(a)
-
Oligonucleotides, Antisense
-
PCSK9 protein, human
-
Proprotein Convertase 9
-
Proprotein Convertases
-
Serine Endopeptidases